Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

With new cancer treatments including immunotherapy and targeted therapy comes more dermatologic adverse events for patients on these treatments. Ciccolini emphasized the importance of referring patients on these therapies to a dermatologic specialist for assessment, education, and planning.

Videos

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies. 

Kathryn Ciccolini on the Increase of Dermatologic AE's With New Cancer Therapies

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the concept she developed to manage dermatologic adverse events for patients with cancer.

Many patients who are taking anticancer therapies experience dermatologic adverse events, so Ciccolini wanted to create an interdisciplinary approach that could help manage and treat these side effects. And so, the CREAM (communication, referral, education, encouragement, assessment, management and monitoring) principles were born.

Kathryn Ciccolini, RN, BSN, OCN, DNC

Articles

Kathryn Ciccolini on the Increase of Dermatologic AE's With New Cancer Therapies

Kathryn Ciccolini Discusses the CREAM Principles to Manage Dermatologic AEs